Popular on TelAve
- Matt Stuckert Joins Lineus Medical Board of Directors - 124
- GoLite Mobile Launches, Merging Premium Wireless with a Mission to Save the Ocean
- Bald Guy Greetings Launches Bold New Postcard Line Celebrating Over-the Top (and Often Delusional) Confidence
- Olga Torres Once Again Recognized as a Top Advisor by Foreign Investment Watch
- Wrights Plastics continue print partnership with HiHi
- Independence Title Honored for Excellence in Fraud Prevention by Stewart Title
- Expert Law Attorneys Nominates 2025 Personal Injury Firms
- Websites.law Named Leading Law Firm Website Design Company of 2025
- PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs
- WoWo Sim Launches New Mobile App for Hassle-Free Global Connectivity
Similar on TelAve
- Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
- Thrive Cannabis Marketplace Opens New Main Street Dispensary in Las Vegas Arts District
- Aries Industries Earns USA Today Top Workplaces Award, Honoring Company as Great Place to Work
- Robinson earns fourth straight supplier award from Rolls-Royce
- Blaming Patients: How Failed Treatments Fuel a $51 Billion Brain Device Industry
- Dentist in London Ontario the Explains Expansion of Canadian Dental Care Plan
- Family Estrangement on the Rise: Therapist Offers Support, Perspective, and Community for Those Affected
- Perfect Body Laser & Aesthetics Launches New Website
- LIB Large-Scale Walk-In Test Chamber Full Process Delivery: MIL-STD-810H Chambers Enable Extreme Environment Testing
- The Ultimate Med Spa Growth Engine: PatientNow and Aesthetix CRM Announce Strategic Integration
Successful Completion of Australia's Therapeutic Goods Administration (TGA) Audit
TelAve News/10831842
SAN JOSE, Calif. - TelAve -- CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods. As a globally recognized peptide and oligonucleotide manufacturer, with our facilities built and operated to WHO GMP, FDA 21 CFR 210/211, and ICH Q7 standards, this audit marks a significant milestone in the company's ongoing commitment to ensuring the highest standards of quality and compliance. Our manufacturing facility in Hangzhou, China, was awarded an A2 compliance rating. This inspection certifies Good Manufacturing Practice (GMP) compliance of three commercial peptide active pharmaceutical ingredients (APIs). This achievement underscores our commitment to maintaining the highest quality standards in peptide production and ensures that our products meet stringent international regulatory requirements.
More on TelAve News
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on TelAve News
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
More on TelAve News
- Guests Can Save 20 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Last-Minute Booking Discount'
- All-Woman Trial Team Wins Major Verdict in Major Case
- Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
- Thrive Cannabis Marketplace Opens New Main Street Dispensary in Las Vegas Arts District
- ReferFriends.io Officially Launches: A New Global Hub for Sharing and Discovering Referral Codes
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on TelAve News
- Emerging Managers Podcast Launches, Highlighting New Players in Venture Capital Outperforming the Status Quo
- North American Security Launches New Website to Reflect Evolving Industry Demands and Client-Centered Solutions
- Home Run Pest & Termite Control Launches Monthly Mosquito Service to Help Wylie, Plano, and Rockwall Homeowners Reclaim Their Backyards
- Jayson Warner Smith joins the cast of Tulsa King, The Good Daughter and Murdaugh Murders in 2025
- Digital Watchdog and Deep Sentinel Partner to Deliver Integrated AI-Powered Security Solutions
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
Source: CPC Scientific Inc.
0 Comments
Latest on TelAve News
- The most Googled celebrity divorces in the UK
- HR Tech Awards Program Celebrates 6th Year: Showcases Top Hiring, Talent, and HR Technologies
- Strike School Unveils Bold New Rebrand with Innovative Educational Solutions for the 2025-2026 School Year
- The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy
- Robinson earns fourth straight supplier award from Rolls-Royce
- PebblePad Welcomes Justin Reilly as New CEO to Drive Innovation and Growth
- "Reflections of WEUSI 1965 – Present" The Intersection of Power, Art, and Wellness for Stress Awareness Month
- Blaming Patients: How Failed Treatments Fuel a $51 Billion Brain Device Industry
- Dentist in London Ontario the Explains Expansion of Canadian Dental Care Plan
- Unlocking the Secrets of Mystery and Magic:
- Nevada Supreme Court Faces Pivotal Decision in Probate Appeal Involving Alleged Judicial Misconduct and Fiduciary Fraud
- Revolutionary Partnership Bridging AI/Youth Sports/Business
- Family Estrangement on the Rise: Therapist Offers Support, Perspective, and Community for Those Affected
- Retirement Income Specialist Daniel Rondberg Joins Tom Hegna on the Exciting New Season of "Financial Freedom with Tom Hegna"
- Village Vapes and Cooking 4 Autism Announce Inaugural Partnership at MEGA 420 EVENT
- Mark Solomon, Sr. Named 2024 Citizen of the Year by Richardson Chamber of Commerce
- Perfect Body Laser & Aesthetics Launches New Website
- American University of Antigua Appoints New Provost and Interim Dean of Preclinical Sciences
- Pro Plus Services Expands Deck and Patio Installation for Residential and Commercial Clients in Massachusetts
- Slotozilla Expands Its Platform with a New Page on Feminism